BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Antibacterial activity in spices and local medicinal plants against clinical isolates of Karachi, Pakistan. ✅
Go to Publication ✅
Pharmaceutical biology (Pharm Biol ) Vol: 49 Issue 8 Pages: 833-9 Pub: 2011 Aug Epub: 2011 Apr 18 Authors Ali NH , Faizi S , Kazmi SU , |
|
|
A comparative study on chemical composition, antibiofilm and biological activities of leaves extracts of four Tunisian olive cultivars. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 5 Pages: e01604 Pub: 2019 May Epub: 2019 May 20 Authors Edziri H , Jaziri R , Chehab H , Verschaeve L , Flamini G , Boujnah D , Hammami M , Aouni M , Mastouri M , |
|
|
A comparative study on chemical composition, antibiofilm and biological activities of leaves extracts of four Tunisian olive cultivars. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 5 Pages: e01604 Pub: 2019 May Epub: 2019 May 20 Authors Edziri H , Jaziri R , Chehab H , Verschaeve L , Flamini G , Boujnah D , Hammami M , Aouni M , Mastouri M , |
|
|
Compounds from Olea europaea and Pistacia lentiscus inhibit oral microbial growth. ✅
Go to Publication ✅
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 19 Issue 1 Pages: 51 Pub: 2019 Feb 26 Epub: 2019 Feb 26 Authors Karygianni L , Cecere M , Argyropoulou A , Hellwig E , Skaltsounis AL , Wittmer A , Tchorz JP , Al-Ahmad A , |
|
|
The bioprofiling of antibacterials in olive leaf extracts via thin layer chromatography-effect directed analysis (TLC-EDA). ✅
Go to Publication ✅
Journal of pharmaceutical and biomedical analysis (J Pharm Biomed Anal ) Vol: 219 Issue Pages: 114916 Pub: 2022 Sep 20 Epub: 2022 Jun 27 Authors Agatonovic-Kustrin S , Gegechkori V , Morton DW , Tucci J , Mohammed EUR , Ku H , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
